2024
DOI: 10.1124/jpet.123.001794
|View full text |Cite
|
Sign up to set email alerts
|

A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-Term Epileptic Seizure Activity, Neurologic Dysfunction and Neurodegeneration

Tanveer Singh,
Sreevidhya Ramakrishnan,
Xin Wu
et al.

Abstract: Children are highly vulnerable to the neurotoxic effects of organophosphates (OPs), which can cause neuronal developmental defects, including intellectual disability, autism, epilepsy, and related comorbidities. Unfortunately, no specific pediatric OP neurotoxicity model currently exists. In this study, we developed and characterized a pediatric rat model of status epilepticus (SE) induced by the OP diisopropylfluorophosphate (DFP) and examined its impact on long-term neurological outcomes. Postnatal day 21 ra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 87 publications
0
3
0
Order By: Relevance
“…Untreated rats had epileptic seizures 30 days after soman exposure, which were significantly reduced in GX-treated animals. We also investigated the ability of GX to mitigate long-term (10-month) neuropsychiatric impairments, chronic neurodegeneration, and neuroinflammation in a pediatric model of acute DFP exposure ( Singh et al, 2024b ). GX has neuroprotective effects against long-term memory dysfunction, neurodegeneration, and neuroinflammation in this OPNA model ( Neff and Reddy, 2024 ), underscorinag the potential use of neurosteroid therapy to mitigate chronic neuropsychiatric sequelae following acute OPNA exposure.…”
Section: Preclinical Profile Of Ganaxolone In Opna and Rse Modelsmentioning
confidence: 99%
“…Untreated rats had epileptic seizures 30 days after soman exposure, which were significantly reduced in GX-treated animals. We also investigated the ability of GX to mitigate long-term (10-month) neuropsychiatric impairments, chronic neurodegeneration, and neuroinflammation in a pediatric model of acute DFP exposure ( Singh et al, 2024b ). GX has neuroprotective effects against long-term memory dysfunction, neurodegeneration, and neuroinflammation in this OPNA model ( Neff and Reddy, 2024 ), underscorinag the potential use of neurosteroid therapy to mitigate chronic neuropsychiatric sequelae following acute OPNA exposure.…”
Section: Preclinical Profile Of Ganaxolone In Opna and Rse Modelsmentioning
confidence: 99%
“…This journal issue presents three studies that used pediatric models to test potential MCs and the long-term impact of neonatal exposure to OP agents. Reddy and colleagues established a pediatric rat model of SE induced by the OP compound DFP ( Singh et al, 2024b ). The observed long-lasting behavioral abnormalities, epileptic seizures, and bilateral brain defects mimic the neurologic sequelae seen in children exposed to OPs.…”
Section: Nerve Agentsmentioning
confidence: 99%
“…In addition, there are three papers on pediatric models of OP neurotoxicity. The first paper describes establishing a pediatric rat model for OP-induced status epilepticus, reflecting longlasting behavioral abnormalities seen in exposed children (Singh et al, 2024b). The second paper investigated tezampanel and caramiphen as effective MCs for soman-induced status epilepticus in infant rats (Furtado et al, 2024).…”
mentioning
confidence: 99%